ImmuneXcite
Latest round
- Series A
Last raised
- Mar 2016
Total raised
- $8.6M
Investors
- 3
About ImmuneXcite
ImmuneXcite, Inc.Founded in 2007 in Lexington, US, ImmuneXcite, Inc. specializes in immunotherapy solutions.ImmuneXcite specializes in innovative biopharmaceutical products designed to enhance immune responses against various diseases. The core offerings include advanced immunotherapies aimed at treating conditions such as cancer and autoimmune disorders. These therapies work by utilizing mechanisms that stimulate the body’s immune system to recognize and attack diseased cells more effectively. Targeted primarily at healthcare providers, the end users of these products are patients undergoing treatment for serious medical conditions.ImmuneXcite generates revenue through a combination of direct-to-consumer sales and strategic partnerships with healthcare institutions. The business model includes subscription-based access to certain therapeutic platforms along with one-time purchases of proprietary treatment regimens. Transactions typically occur through agreements with hospitals and oncology clinics, where healthcare providers purchase treatments for patient administration. Specific pricing structures for these therapies are established based on the complexity of the treatments and the associated healthcare costs.ImmuneXcite's future growth strategy includes the development of new immunotherapy products aimed at enhancing treatment options for patients with cancer and autoimmune disorders. The company is also planning to expand its presence in European markets by 2025, particularly focusing on partnerships with local healthcare providers to increase accessibility.6 mn will be pivotal in supporting these initiatives, enabling the company to advance its product pipeline and execute its market expansion plans.
Who invested in ImmuneXcite
3 investors across 1 round
See all investors in ImmuneXcite
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 30, 2016
Amount
$8.6M
Investors
Questions about ImmuneXcite
Who invested in ImmuneXcite?
ImmuneXcite has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmuneXcite raised?
ImmuneXcite has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ImmuneXcite last raise money?
ImmuneXcite's most recent round on record is a Series A, in Mar 2016.
What does ImmuneXcite do?
ImmuneXcite is a biotechnology company.
Where is ImmuneXcite headquartered?
ImmuneXcite is headquartered in Lexington, US.
Which VCs invest in companies like ImmuneXcite?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ImmuneXcite's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ImmuneXcite? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.